pillbase.ru

Radicava

Active substance: edaravone

edaravone

Centralised EU authorisationActive

Marketing holder: Mitsubishi Tanabe Pharma GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • Edaravone
    INJECTION, SOLUTION · EDARAVONE 30 mg/100mL
    66794-259
    Piramal Critical Care Inc.
  • Edaravone
    INJECTION · EDARAVONE 30 mg/100mL
    0781-3527
    Sandoz Inc
  • RADICAVA ORS
    KIT · edaravone
    70510-2322
    Shionogi Inc.
  • RADICAVA ORS
    KIT · edaravone
    70510-2321
    Shionogi Inc.
  • edaravone
    INJECTION, SOLUTION · EDARAVONE 30 mg/100mL
    68083-500
    Gland Pharma Limited
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-7e87-7bfa-974b-eb3bc4c62d9b,01a1208d-8a2d-78e3-9d32-1f4d7361f7a3,01a1208d-8a32-7392-9f3e-97ab393d97aa,01a1208e-d847-7292-93be-4ca528bf50a9,01a12093-0ea3-79a5-9382-c53ce7d4ad1f;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004938
Registration status
Active
ATC code
N07
Sources
  • product · EMA · EMEA/H/C/004938 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004938 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004938 · Verified 2026-10-09